Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Advanced Tumors × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 245 Neoplasms 232 Carcinoma, Non-Small-Cell Lung 215 Prostatic Neoplasms 148 Colorectal Neoplasms 132 Lung Neoplasms 124 Neoplasm Metastasis 119 Leukemia, Myeloid, Acute 104 Ovarian Neoplasms 101 Multiple Myeloma 94 Pancreatic Neoplasms 78 Recurrence 76 Squamous Cell Carcinoma of Head and Neck 67 Endometrial Neoplasms 64 Brain Neoplasms 62 Carcinoma, Hepatocellular 61 Stomach Neoplasms 60 Triple Negative Breast Neoplasms 56 Melanoma 56 Carcinoma, Renal Cell 56 Urinary Bladder Neoplasms 54 Hematologic Neoplasms 50 Lymphoma, Non-Hodgkin 49 Leukemia, Lymphocytic, Chronic, B-Cell 49 Lymphoma, Large B-Cell, Diffuse 47 Small Cell Lung Carcinoma 46 Precursor Cell Lymphoblastic Leukemia-Lymphoma 45 Head and Neck Neoplasms 44 Glioblastoma 43 Sarcoma 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06245122 2026-04-06

A Study of CS23546 in Subjects With Advanced Tumors

Chipscreen Biosciences, Ltd.

Phase 1 Recruiting

Advanced Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡